Axolotls’ and Mices’ Oral-Maxillofacial Trephining Wounds Heal Differently
Cells Tissues Organs · 2021 · 210 (4) · 260-274
DOI: 10.1159/000518036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells Tissues Organs, online erschienen am 01.07.2021. Verfasst von Andre Marc Charbonneau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, Québec, Canada, andre.charbonneau2@mail…. Hauptthemen laut MEDLINE: Ambystoma mexicanum, Trephining. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: CIHR.
Abstract (Originalsprache)
The Ambystoma maxicanum (axolotl) regenerates strikingly from wounds and amputations. Comparing its healing ability to non-regenerative species such as the mouse should help narrow in on mechanisms to improve human wound healing. Here, the tongue and intermandibular soft tissues of both mice (C57BL/6NCrl) and axolotls were wounded with a 2–2.5 mm punch biopsy. The study aimed to compare the differences between these 2 species following surgical resection with regard to the macroscopic and histological characteristics. These include wound closure times, epithelial wound sealing and thickness as well as acute immune marker myeloperoxidase (MPO) response over 30 days. Post surgery, mice visually showed greater haemorrhage; their wounds immediately collapsed while it took 14 days for the axolotls mandibular void to close. The epithelium sealed the axolotls’ wound margins within 24 h with a maximal mean thickness of 0.42 ± 0.13-fold normalized to unwounded skin. In mice, the epithelium separately sealed the ventral and dorsal sides, respectively at 7 and 7–30 days with mean maximal epithelial thicknesses reaching 13 ± 5.6 and 3.0 ± 0.63-fold. Mean MPO-positive cell values peaked in axolotls at 14 ± 1.5-fold between hours 6–12; while in mice, it peaked at 8.7 ± 0.9-fold between hours 24–96. We conclude that axolotls form smaller blood clots, have a faster and thinner epithelial cell migrating front, and a shorter MPO-positive cell response in comparison to mice. These observations may help refine future oral and facial wound-healing research and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, Québec, Canada, andre.charbonneau2@mail.mcgill.ca.
- Cancer and Translational Medicine Research Unit, University of Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland, andre.charbonneau2@mail.mcgill.ca.
- Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland and HUSLAB, Helsinki University Hospital, Helsinki, Finland, andre.charbonneau2@mail.mcgill.ca.
- Cancer and Translational Medicine Research Unit, University of Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
- Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland and HUSLAB, Helsinki University Hospital, Helsinki, Finland.
- Department of Stomatology, University de Montreal, Montreal, Québec, Canada.
Förderung
- CIHR
Zitieren
APA
Charbonneau, A. M., Åström, P., Salo, T., Roy, S., & Tran, S. D. (2021). Axolotls’ and Mices’ Oral-Maxillofacial Trephining Wounds Heal Differently. Cells Tissues Organs, 210(4), 260-274. https://doi.org/10.1159/000518036
Vancouver
Charbonneau AM, Åström P, Salo T, Roy S, Tran SD. Axolotls’ and Mices’ Oral-Maxillofacial Trephining Wounds Heal Differently. Cells Tissues Organs. 2021;210(4):260-274. doi:10.1159/000518036
BibTeX
@article{Charbonneau2021,
author = {Charbonneau, Andre Marc and Åström, Pirjo and Salo, Tuula and Roy, Stéphane and Tran, Simon D},
title = {Axolotls’ and Mices’ Oral-Maxillofacial Trephining Wounds Heal Differently},
journal = {Cells Tissues Organs},
year = {2021},
volume = {210},
number = {4},
pages = {260--274},
doi = {10.1159/000518036}
}
EUVIMED